Researchers at the National Institutes of Health and the University of Hong Kong have discovered that high levels of a particular protein in cancer cells are a reliable indicator that a cancer will spread.
Vertex Pharmaceuticals Inc. reported a larger fourth-quarter loss as it spent more money to develop its hepatitis C drug candidate telaprevir, along with a potential cystic fibrosis treatment and other drugs.
Hamilton Robotics introduces a 1 mL 96-channel pipetting head for its MICROLAB STAR and NIMBUS liquid handling workstations. Incorporating Hamilton’s CO-RE technology, the new 1 mL multi-pipetting head offers a higher dynamic pipetting range.
Agilent Technologies Inc. announced the addition of the BenchBot Robot to its line of automated microplate handling equipment. The BenchBot is a mid-sized microplate handler designed to meet the automation workflow needs of diverse laboratories.
Agilent Technologies Inc. announced the launch of the AssayMAP Bravo platform and protein purification cartridges, a fully automated solution for high-throughput protein sample preparation and purification.
LabAutomation2011, the world’s leading conference and exhibition on emerging laboratory automation technologies, welcomed 4,407 participants from around the world to the Palm Springs Convention Center, Palm Springs, CA, USA, January 29-February 2, 2011.
Bio-Rad Laboratories, Inc.'s newly released EpiQ chromatin analysis kit is a real-time PCR assay for the rapid quantitative assessment of chromatin structure.
DNAnexus, Inc. announced the availability of a comprehensive set of new informatics tools that enable life science researchers to efficiently analyze and manage large-scale genomic variation datasets in a cloud-based workflow.
Caliper Life Sciences, Inc. announced a collaboration with the John P. Hussman Institute for Human Genomics to develop automated protocols for exome capture and library preparation workflows.
Eli Lilly and Company and the Juvenile Diabetes Research Foundation (JDRF) announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.
A new report indicates that low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment.
A new study highlights inconsistencies in black box warnings and argues for a more transparent and systematic approach to ensure these warnings are consistent across all drugs within the same category.
Derma Sciences, Inc. announced positive results from its Phase 2 clinical trial with DSC127 in patients with diabetic foot ulcers, including meeting the trial’s primary endpoint, the proportion of study ulcers healed by 12 weeks.
Valeant Pharmaceuticals International Inc. said that its Biovail unit will pay $300 million for U.S. and Canadian rights for non-eye-care uses for GlaxoSmithKline's Zovirax. Zovirax is an antiviral cream.
Standard & Poor's Ratings Services said that its credit ratings on Sanofi-Aventis SA remain on watch for possible downgrade pending the outcome of the French drugmaker's proposed bid for biotechnology company Genzyme Corp.